Top Markets
#1 DogBull DogBull +54.73%
#2 Siren Siren +30.85%
#3 OriginTrail OriginTrail +22.47%
#4 Yield Basis Yield Basis +13.33%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.09%
#6 Purr Purr +10.17%
#7 Cysic Cysic +9.76%
#8 COTI COTI +9.02%
#9 Stargate Finance Stargate Finance +8.63%
#10 Ethena Staked ENA Ethena Staked ENA +7.12%
Coin of the day
DogBull DogBull
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BIONET Corp. BIONET Corp.

BIONET Corp.

1784
Rangering i aksjer #21907
Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a... Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cell banking services, encompassing the storage of general stem cells, mesenchymal stem cells, dental stem cells, adipose stem cells, and peripheral blood stem cells combined with immune cells. Beyond its core stem cell preservation, BIONET also conducts genetic testing services. Its product offerings further extend to anti-aging solutions leveraging stem cell technology, alongside its unique ANIKINE series. Additionally, the company is a pioneer in offering Exosome, an innovative cell-free therapeutic approach.
Aksjekurs
$1.95
Sist synkronisert: 2026-08-21
Markedsverdi
$98.22M
Endring (1 dag)
-0.16%
Endring (1 år)
-22.25%
Land
TW
Handel BIONET Corp. (1784)

Kategori

Healthcare
Inntekter for BIONET Corp. (1784)
Inntekter i 2026 TTM: 0
Ifølge BIONET Corp. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for BIONET Corp. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH